Introduction

As per its tradition, this dynamic four day symposium aims to bring together medicinal chemists from across the country, and around the globe, working in the pharmaceutical industry, academia, regulatory agencies and private research institutions. The 2024 edition will be co-chaired by:

Rheem A. Totah, University of Washington
Patrick J. Burke, Enlaza Therapeutics

The Scientific Organizing Committee will arrange a distinguished lineup of speakers. For four days, Seattle will be the setting of a high-profile and international scientific meeting. The scientific program will be composed of six sessions presenting hot topics and emerging trends in medicinal chemistry and drug discovery. In addition, the MEDI Awards will be celebrated as part of a dedicated session.

Participants will be encouraged to submit abstracts to share their ideas and results. Several poster prizes will be awarded during the meeting.

Deadlines

• Feb 14 2024
  Early bird registration deadline

  
• Mar 14 2024
  Poster abstract deadline

  
• Jun 01 2024
  Standard registration deadline

  

Useful links

• Further event details More information about the event

Speakers

• Dr Maria-Jesus BLANCO ATAVISTIK BIO, Cambridge, United States
• Dr Nicholas MEANWELL BRISTOL MYERS SQUIBB, Wallingford, United States
• Prof. Richard B. SILVERMAN NORTHWESTERN UNIVERSITY, Evanston, United States
• Prof. Michelle ARKIN UNIVERSITY OF CALIFORNIA, San Francisco, United States
• Dr. Matthew HAYWARD MAGNET BIOMEDICINE, Boston , United States
• Dr Kat KAYSER-BRICKER HALDA THERAPEUTICS, New Haven, United States
• Dr Lingling SHEN NOVARTIS, Cambridge, United States
• Dr Owen WALLACE MONTE ROSA THERAPEUTICS, Boston, United States
• Prof. Ning ZHENG UNIVERSITY OF WASHINGTON, Seattle, United States
• Prof. Rong HUANG PURDUE UNIVERSITY, West Lafayette, IN, United States
• Prof. Jian JIN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, New York, United States
• Dr Christopher SMITH MIRATI THERAPEUTICS, San Diego, United States
• Dr David DREWRY UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, Chapel Hill, United States
• Dr Jennifer GOLDEN UNIVERSITY OF WISCONSIN, Madison, United States
• Dr John A. MCCAULEY MERCK & CO. INC, Blue Bell, PA, United States
• Dr Rebecca ABERGEL UNIVERSITY OF CALIFORNIA, Berkeley, United States
• Dr Raffaele COLOMBO ZYMEWORKS, Vancouver, Canada
• Dr Sharsti SANDALL SEAGEN, Bothell, United States
• Dr Arvin DAR MEMORIAL SLOAN KETTERING CANCER CENTER, New York, United States
• Dr John TOKARSKI BRISTOL MYERS SQUIBB, New York, United States
• Dr Angela TOMS NIMBUS THERAPEUTICS, INC., Cambridge, United States
• Dr Bernd KUHN F. HOFFMANN-LA ROCHE, Basel, Switzerland
• Dr Veerabahu SHANMUGASUNDARAM BRISTOL MYERS SQUIBB, CAMBRIDGE, United States
• Prof. Peter TONGE STONY BROOK UNIVERSITY, Stony Brook, United States
• Prof. Marcey WATERS UNIVERSITY OF NORTH CAROLINA , Chapel Hill, United States
• Dr David WEINSTEIN VIVIDION THERAPEUTICS, San Diego, United States
• Dr Gaurav BHARDWAJ UNIVERSITY OF WASHINGTON, Seattle, United States
• Dr Gavin HIRST ATOMWISE, San Francisco, United States
• Dr Jennifer KNIGHT SCHRODINGER, New York, United States
• Dr Mark MURCKO DISRUPTIVE BIOMEDICAL, LLC, Holliston, United States
• Dr Pat WALTERS RELAY THERAPEUTICS, Cambridge, United States
• Dr Matt WELBORN ENTOS, INC., La Jolla, United States

---

Sponsorship & supporting organisations

---

Sponsors

American Chemical Society

ACS Division of Medicinal Chemistry

Venue

Sheraton Grand Seattle

Sheraton Grand Seattle, 1400 6th Avenue, Seattle, WA , 98101, United States

Useful links

• Venue information More information about the venue

Committee

• Dr Patrick BURKE Enlaza Therapeutics, San Diego, United States
• Dr Rheem A. TOTAH University of Washington, Lake Forest Park, WA, United States

---

Contact information

LDOrganisation
+32 10 45 47 77
Contact us by email

---